ClinicalTrials.govpublic full text
A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies
hematologic malignancies, lymphoma, cd19-positive, relapsed/refractory, b-cell hematologic malignancies, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 832992
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.